Search - tctmd.com

Displaying 321 - 340 of 433

Sort: Relevancy | Date

Presentation TCT 2012

ACE-CTO: Angiographic Follow-up After Everolimus-eluting Stents in CTO

Presenter: Emmanouil Brilakis

October 22, 2012

News Industry News

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012(2)

October 16, 2012

News Industry News

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012

October 16, 2012

News Daily News

Stent Fractures Persist Among Newer-Generation Devices

Jason Kahn

October 02, 2012

News Daily News

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

September 19, 2012

News Daily News

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

Yael L. Maxwell

September 07, 2012

News Conference News ESC 2012

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

Caitlin E. Cox

August 29, 2012

News Conference News ESC 2012

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

Caitlin E. Cox

August 29, 2012

Presentation ESC 2012

Optical Coherence Tomography to Compare Paclitaxel-Eluting Balloons with Everolimus-Eluting Stents

Presenter: Tudor C. Poerner

August 27, 2012

News Industry News

Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent

August 20, 2012

News Daily News

Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease

Caitlin E. Cox

August 16, 2012

News Daily News

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

L.A. McKeown

July 30, 2012

Presentation

RESET: Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents

Presenter: Takeshi Kimura

July 27, 2012

News Daily News

Xience V Noninferior to Cypher for Primary PCI

July 24, 2012

News Daily News

El Xience V No es Inferior al Cypher en PCI Primarias

July 24, 2012

News Daily News

Japanese Registry Confirms PCI, CABG ‘Comparable’ for Less Complex Left Main Disease

Caitlin E. Cox

June 28, 2012

News Daily News

Meta-analysis: Less Stent Thrombosis at 2 Years with EES vs. Other DES

Leah Lawrence

June 15, 2012

Presentation

Stent Thrombosis with Everolimus-Eluting Stents

Presenter: T. Palmerini

June 14, 2012

News Industry News

Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element™ Plus Platinum Chromium Stent System

June 04, 2012

News Daily News

Meta-analysis: Superior Efficacy with DES at No Cost to Safety

May 22, 2012

Advertisement

ACE-CTO: Angiographic Follow-up After Everolimus-eluting Stents in CTO

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012(2)

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012

Stent Fractures Persist Among Newer-Generation Devices

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

SORT OUT IV: Xience Holds Edge Over Cypher for Preventing Stent Thrombosis

Stem Cells, Nanoparticles Appear to be an Antidote to Atherosclerosis

OCTOPUS Looks at Vessel Healing After DES vs. BMS Plus Paclitaxel Balloon

Optical Coherence Tomography to Compare Paclitaxel-Eluting Balloons with Everolimus-Eluting Stents

Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent

Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease

RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year

RESET: Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents

Xience V Noninferior to Cypher for Primary PCI

El Xience V No es Inferior al Cypher en PCI Primarias

Japanese Registry Confirms PCI, CABG ‘Comparable’ for Less Complex Left Main Disease

Meta-analysis: Less Stent Thrombosis at 2 Years with EES vs. Other DES

Stent Thrombosis with Everolimus-Eluting Stents

Boston Scientific Receives FDA Approval for 32 MM and 38 MM Lengths for PROMUS Element™ Plus Platinum Chromium Stent System

Meta-analysis: Superior Efficacy with DES at No Cost to Safety

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content